EBV-specific killer T lymphocytes

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-specific killer T lymphocytes, covering 2015-01-29 to 2015-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts [Phase 1]

See pricing